By Ludwig Burger and Ariane Luthi (Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a ...

The pharmaceutical giant said it has agreed to acquire the U.S. privately held, clinical-stage biopharmaceutical company to ...

Shares of Blackstone Inc. BX slipped 2.27% to $164.78 Tuesday, on what proved to be an all-around great trading session for ...

Retail Opportunity Investments Corp. investors agreed to sell the company for $17.50 per share, a roughly 34% premium from ...

Steve Schwarzman knows a thing or two about wealth. It’s no wonder that Blackstone , the investing colossus he runs, found a ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

After making Super Bowl history with Kendrick Lamar in 2022, Willingboro native Adam Blackstone is set to return for a ...

Blackstone, a major global investor in data centers that run A.I. systems, expects use of the technology to rise as the cost ...

Blackstone beat estimates for fourth-quarter profit on Thursday, driven by a pickup in dealmaking, while executives at the ...

--(BUSINESS WIRE)--Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for ...

Net income for the quarter totaled $1.3 billion, or $0.92 per share, in a 1,120% increase from $109 million a year earlier.

Hans-Holger Albrecht, Chairman of Superbet Group, noted the confidence that Blackstone and HPS have placed in the company’s ...